Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case-control study

Eur J Prev Cardiol. 2022 May 5;29(5):e193-e195. doi: 10.1093/eurjpc/zwab142.

Authors

Mizuki Sata¹, Akemi Kakino^{2

3}, Aya Hirata¹, Miho Iida¹, Yoko Usami⁴, Sei Harada¹, Yoshiko Fujita², Shun Kohsaka⁵, Yoshikane Izawa⁶, Mitsuaki Sawano⁵, Koichi Oki⁷, Daisuke Sugiyama^{1

8}, Shinichi Takahashi⁹, Toru Takebayashi¹, Tatsuya Sawamura^{2

3}, Tomonori Okamura¹

Affiliations

¹ Department of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
² Department of Molecular Pathophysiology, School of Medicine, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
³ Institute for Biomedical Sciences, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
⁴ Department of Laboratory Medicine, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
⁵ Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
⁶ Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
⁷ Department of Neurology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato, Tokyo 108-0073, Japan.
⁸ Faculty of Nursing and Medical Care, Keio University, 4411 Endo, Fujisawa, Kanagawa 252-0883, Japan.
⁹ Department of Neurology and Stroke, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan.

PMID: 34472612
DOI: 10.1093/eurjpc/zwab142

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Atherosclerosis* / diagnosis
Atherosclerosis* / epidemiology
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Case-Control Studies
Cholesterol, HDL
Humans
Japan / epidemiology
Lipoproteins, HDL
Risk Factors

Substances

Cholesterol, HDL
Lipoproteins, HDL